This page looks different to our usual site because it is older content. More recent articles are here.


Aims of EHV-1 research outlined

June 1, 2011

» Latest state-by-state EHV-1 wrap

Four studies are being funded by a US foundation to develop effective therapies against Equine Herpesvirus 1 (EHV-1), an outbreak of which is affecting western states.

The virus infected at least 41 horses last month, and restrictions on affected properties remain in place to reduce the chances of the potentially deadly virus spreading.

Morris Animal Foundation-funded researchers are studying the virus with the goal of identifying new targets for developing more effective therapies and vaccines to treat and prevent EHV-1 infection, respectively.

When horses are infected with EHV-1, the clinical signs can be scary for any owner.

The virus can cause a variety of ailments in horses, including rhinopneumonitis, a respiratory disease usually found in young horses; abortion in broodmares; and myeloencephalopathy, which includes fever, incoordination, weakness or paralysis of the hind limbs and incontinence.

The virus is generally passed from horse to horse when affected animals sneeze or cough and through contact with nasal secretions.

With funding from Morris Animal Foundation, researchers at Colorado State University, Cornell University and Freie Universität Berlin are working in their labs to unlock the mysteries of EHV-1.

Dr Gisela Soboll Hussey, from Colorado State University, is using an equine airway culture system to study the role of specific genes that may impair a horse's early immune response to EHV-1.

This new information will identify new targets for developing therapies and will have wide-ranging impacts on the ability to design effective EHV-1 vaccines that could prevent infection.

EHV-1 can also cause spinal cord injuries that lead to devastating neurological disease.

Mildly affected horses may only lose tail sensation, but severely affected horses are often paralysed and must be euthanised. These injuries occur because blood clots form in the horse's blood vessels, starving the spinal cord of oxygen.

Why horses with EHV-1 develop these blood clots is unknown, but at Cornell University, Dr Tracy Stokol is looking at whether EHV-1 produces blood clots by infecting cells within the bloodstream or cells lining the blood vessels and turning them into clot-forming agents.

Her findings could help decrease the rate of euthanasia in affected horses.

In another foundation-funded study at Cornell University, Dr Bettina Wagner is working to develop novel tools for studying the equine immune system that will help the equine research community diagnose a wide variety of equine infectious diseases, including EHV-1.

This project will contribute to the development of new and improved vaccines and novel treatment strategies for equine veterinarians.

Dr Nikolaus Osterrieder, at the Freie Universitšt Berlin in Germany, has successfully identified an EHV-1 protein that enables herpesviruses to hide within cells and avoid destruction by the horse's immune system.

By understanding the molecular mechanism that enables EHV-1 to hide from the immune system, researchers hope to develop improved vaccines that are capable of inducing better protection against this devastating disease.

The foundation funds studies like these all over the world, made possible by generous donations and continued support from animal lovers.



Affiliate disclaimer